Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas.
Cell Death Dis. 2024 Jul 22;15(7):521. doi: 10.1038/s41419-024-06894-1.
Cell Death Dis. 2024.
PMID: 39039067
Free PMC article.
BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models.
Guffanti F, Mengoli I, Alvisi MF, Dellavedova G, Giavazzi R, Fruscio R, Rulli E, Damia G.
Guffanti F, et al. Among authors: mengoli i.
Front Pharmacol. 2024 Jun 25;15:1390116. doi: 10.3389/fphar.2024.1390116. eCollection 2024.
Front Pharmacol. 2024.
PMID: 38989145
Free PMC article.
Item in Clipboard
Current HRD assays in ovarian cancer: differences, pitfalls, limitations, and novel approaches.
Guffanti F, Mengoli I, Damia G.
Guffanti F, et al. Among authors: mengoli i.
Front Oncol. 2024 Aug 16;14:1405361. doi: 10.3389/fonc.2024.1405361. eCollection 2024.
Front Oncol. 2024.
PMID: 39220639
Free PMC article.
Review.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.